Noticias de CEP | Roxom Stocks

1 BTC

=

- USD

Loading market data...

CE

Cap. mercado

N/A

Volumen

N/A

Próximos resultados

N/A

Gráfico Resultados Noticias Acerca de Insiders Reportes

Immatics Announces $125 Million Underwritten OfferingImmatics N.V. plans to sell 12.5 million ordinary shares at $10.00 per share, expecting to raise $125 million in a public offering managed by Jefferies, Leerink Partners, and Cantor.GlobeNewswire Inc. · Dec 5, 2025

Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded WarrantsInhibikase Therapeutics is conducting a public offering of common stock and pre-funded warrants, raising approximately $100 million to support its clinical-stage pharmaceutical development for pulmonary arterial hypertension.GlobeNewswire Inc. · Nov 21, 2025

Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded WarrantsInvivyd is conducting a public offering of 44 million common stock shares and 6 million pre-funded warrants at $2.50 per share, expecting to raise approximately $125 million to fund commercial preparedness, research and development, and corporate purposes.GlobeNewswire Inc. · Nov 18, 2025

Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded WarrantsDisc Medicine has priced a public offering of common stock and pre-funded warrants, expecting to raise approximately $225 million to support potential drug commercialization and research efforts.Benzinga · Oct 21, 2025

Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded WarrantsDisc Medicine has priced a public offering of common stock and pre-funded warrants, expecting to raise approximately $225 million to support potential commercialization of bitopertin and fund research and development.GlobeNewswire Inc. · Oct 21, 2025

Zealand Pharma to participate in upcoming investor conferences in September 2025Zealand Pharma will participate in multiple healthcare investor conferences in September 2025, with key executives hosting meetings and participating in fireside chats across events in Zürich, New York, Boston, London, and Brussels.GlobeNewswire Inc. · Aug 28, 2025

Compass Therapeutics to Participate in Upcoming September Investor EventsCompass Therapeutics will participate in multiple healthcare and investment conferences in September 2025, including events in Boston and New York, presenting their oncology-focused antibody-based therapeutics research.GlobeNewswire Inc. · Aug 26, 2025

Trump Insiders Want A Piece Of Crypto, SPAC Action: Is A Merger Coming?Two executives with ties to Donald Trump and Trump Media & Technology Group have launched a SPAC targeting the cryptocurrency sector, which could attract investor attention given recent crypto-related merger announcements that have seen shares soar.Benzinga · May 15, 2025

Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor FitzgeraldTevogen CEO Dr. Ryan Saadi will participate in a panel discussion on strategies for adapting to market volatility at the BioNJ Bio Partnering Conference, along with experts from J.P. Morgan, RSM, and Cantor Fitzgerald.GlobeNewswire Inc. · Apr 14, 2025

Why Rocket Lab Stock Is Sinking TodayRocket Lab stock is down 5.3% after a 28% surge the previous day, as Cathie Wood's Ark Invest firm takes some profits. However, analysts remain bullish, with Cantor Fitzgerald and Bank of America raising their price targets on the stock.The Motley Fool · Nov 14, 2024

CE

CEPCEP

CEP

Pagar con—

Empezar a operar

Saldo disponible0,00

Tu posiciónAún no tienes CEP.

Tickers relacionados

Resultados